MedPath

Adenosine

Approved
Approval ID

91a601ab-d3cc-4013-9108-1b5432476076

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 9, 2022

Manufacturers
FDA

Akorn

DUNS: 117693100

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Adenosine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code17478-953
Application NumberANDA078076
Product Classification
M
Marketing Category
C73584
G
Generic Name
Adenosine
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 26, 2017
FDA Product Classification

INGREDIENTS (3)

AdenosineActive
Quantity: 3 mg in 1 mL
Code: K72T3FS567
Classification: ACTIB
WaterInactive
Code: 059QF0KO0R
Classification: IACT
Sodium ChlorideInactive
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.